Razadyne and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Razadyne (galantamine hydrobromide) and Lovenox (enoxaparin sodium). Common drug interactions include cerebrovascular accident among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Razadyne and Lovenox. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Razadyne?

Razadyne has active ingredients of galantamine hydrobromide. It is often used in insomnia. eHealthMe is studying from 691 Razadyne users. Check the latest studies of Razadyne.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.



On Jul, 11, 2026

11 people who take Razadyne and Lovenox together, and have interactions are studied.

Razadyne and Lovenox drug interactions.

What are the common drug interactions of Razadyne and Lovenox, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes)
  3. Hemiplegia (paralysis of one side of the body)
  4. Neurologic neglect syndrome (neuropsychological condition in which, after damage to one hemisphere of the brain is sustained, a deficit in attention to and awareness of one side of space is observed)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Hallucination (an experience involving the perception of something not present)
  7. Pneumonia

male:

  1. Anxiety
  2. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pneumonia
  6. Visual field defect
  7. Apnoea (suspension of external breathing)
  8. Bruxism (habitual grinding of the teeth, typically during sleep)
  9. Hypopnoea (decrease in the breathing rate)
  10. Snoring

What are the common drug interactions of Razadyne and Lovenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Anxiety
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pneumonia
  6. Visual field defect
  7. Apnoea (suspension of external breathing)
  8. Bruxism (habitual grinding of the teeth, typically during sleep)
  9. Hypopnoea (decrease in the breathing rate)
  10. Snoring

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 3 people, 27.27%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 27.27%
  3. High Blood Pressure: 3 people, 27.27%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  5. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 3 people, 27.27%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 18.18%
  7. Age-Related Macular Degeneration: 2 people, 18.18%
  8. Urinary Tract Infection: 1 person, 9.09%
  9. Pneumonia: 1 person, 9.09%
  10. Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Razadyne and Lovenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Razadyne and Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Razadyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Razadyne and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on galantamine hydrobromide and enoxaparin sodium (the active ingredients of Razadyne and Lovenox, respectively), and Razadyne and Lovenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: